Table of Contents

2019-2024 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size 2014-2024
2.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size CAGR by Region
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 Other
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
2.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.4.3 Other
2.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
2.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment by Players
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Players (2017-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Amyotrophic Lateral Sclerosis (ALS) Treatment by Regions
4.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions
4.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth
4.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth
4.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth

5 Americas
5.1 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Countries
5.2 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
5.3 Americas Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Countries
6.2 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
6.3 APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment by Countries
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment by Countries
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast
10.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Forecast (2019-2024)
10.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions
10.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Type
10.8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecast by Application

11 Key Players Analysis
11.1 Mitsubishi Tanabe Pharma
11.1.1 Company Details
11.1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Mitsubishi Tanabe Pharma News
11.2 Sanofi
11.2.1 Company Details
11.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Sanofi News
11.3 Mylan Pharma
11.3.1 Company Details
11.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Mylan Pharma News
11.4 Apotex
11.4.1 Company Details
11.4.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Apotex News
11.5 Glemark Generics
11.5.1 Company Details
11.5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Glemark Generics News
11.6 Covis Pharma
11.6.1 Company Details
11.6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Covis Pharma News
11.7 Sun Pharma
11.7.1 Company Details
11.7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Sun Pharma News
11.8 Lunan Pharma
11.8.1 Company Details
11.8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Lunan Pharma News

12 Research Findings and Conclusion